Congress Park Capital’s GSK GSK Stock Holding History

Congress Park Capital’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-6,970	Closed	-$205K	–	141
2022 Q3	$205K	Buy	+6,970	New	+$264K	0.12%	121
2021 Q3	–	Sell	-4,400	Closed	-$219K	–	140
2021 Q2	$219K	Sell	4,400 -800	-15%	-$38.4K	0.11%	124
2021 Q1	$232K	Buy	+5,200	New	+$236K	0.13%	111

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

AWA

Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Congress Park Capital's GSK Position: Q4 2022 in Review

Congress Park Capital sold out of GSK (GSK) in Q4 2022, closing a stake of 6,970 shares — an estimated $205K sold.

Congress Park Capital first reported a position in GSK in Q1 2021 and held it in 3 quarters. The position peaked at $232K in Q1 2021. 813 funds tracked by Wall St. Rank hold GSK as of Q4 2022.

Congress Park Capital reported no remaining GSK position as of Q4 2022 after selling out during the quarter.
Congress Park Capital sold 6,970 GSK shares in Q4 2022, an estimated $205K.
Congress Park Capital first reported a position in GSK in Q1 2021 and held it in 3 quarters.
Congress Park Capital's GSK position peaked at $232K in Q1 2021.
813 funds tracked by Wall St. Rank held GSK as of Q4 2022.

Based on Congress Park Capital's 13F filing for Q4 2022, filed 30 Jan 2023.